Working… Menu

Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02859857
Recruitment Status : Completed
First Posted : August 9, 2016
Last Update Posted : February 17, 2021
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
Bexion Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 17, 2019
Actual Study Completion Date : June 15, 2020